Ignite Creation Date:
2024-05-05 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 9:36 AM
Study NCT ID:
NCT00529113
Status:
TERMINATED
Last Update Posted:
2024-02-02
First Post:
2007-09-12
Brief Title:
Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer
Sponsor:
Reata a wholly owned subsidiary of Biogen
Organization:
Biogen